课题基金 / 基金详情

Molecular interactions of inflammation and beta-amyloid-associated degeneration in muscle as pathomechanisms of Inclusion Body Myositis

Molecular interactions of inflammation and beta-amyloid-associated degeneration in muscle as pathomechanisms of Inclusion Body Myositis
肌肉炎症和β-淀粉样蛋白相关变性的分子相互作用作为包括肌炎在内的病理机制
批准号:
30777987
负责人:
Professor Dr. Jens Schmidt
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2006
资助国家:
德国
项目状态:
已结题
起止时间:
2005-12-31 至 2009-12-31

项目摘要

项目成果

Professor Dr. Jens Schmidt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Sporadic Inclusion Body Myositis (sIBM) is a severely disabling myopathy for that no effective treatment is available. Cleaved from amyloid-precursor-protein (APP), ß-amyloid accumulates in the fibers, which display an inflammatory response along with invasion by cytotoxic T-cells. It is unknown whether inflammatory and degenerative pathomechanisms are independent or interrelate with another. The objective is to define the interplay between inflammation, ß-amyloid-associated cell-stress and degeneration in human muscle cells. Based upon preliminary data, we propose the following specific aims to test our central hypothesis that overexpression of APP triggers cell-stress and interrelates with inflammation in muscle: 1) By over-expression of APP in primary human myo-tubes, we expect to identify degeneration-associated conditions that cause a persistent inflamma-tory and cell-stress response; reciprocally, the inflammation is expected to fuel the toxicity of intra-cellular accumulation of ß-amyloid and prevent recovery from cell-stress. 2) Under conditions of cell-stress inflicted by nitric oxide, gene-silencing of APP is anticipated to prevent degeneration of muscle cells caused by ß-amyloid accumulation. The results are expected to substantially add to our knowledge of molecular muscle biology and extend our understanding of the pathology and potential treatment of sIBM as well as of neurodegenerative disorders as Alzheimer¿s dementia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Untersuchung molekularer Mechanismen, die zur Entstehung und Unterhaltung der Einschlusskörperchenmyositis führen
Optimism in IBM: a dbRCT Phase III trial of sirolimus in patients with IBM to slow disease progression as measured by the IBM functional rating scale (IBM-FRS)
  • 批准号:
    499884453
  • 项目类别:
    Clinical Trials
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professor Dr. Jens Schmidt
  • 依托单位:
国内基金
海外基金
多维数据辨析法用于兽药与生物大分子作用体系的研究
  • 批准号:
    21065007
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2010
  • 负责人:
    倪永年
  • 依托单位:
MBR中溶解性微生物产物膜污染界面微距作用机制定量解析
  • 批准号:
    50908133
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2009
  • 负责人:
    梁爽
  • 依托单位: